drugset / Trial / NCT00221156
Acarbose and Secondary Prevention After Coronary Stenting
Phase 3
Completed
300 enrolled
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Institute of Biomedical Research and Innovation, Kobe, Hyogo, Japan · collabKobe City General Hospital · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to determine whether the intervention for newly diagnosed abnormal glucose tolerance after coronary stenting will improve the long-term clinical outcome.
Timeline
- Start
- 2005-05
- Primary completion
- —
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acarbose | Unknown | — | — |